Logo image of HMC

HONDA MOTOR CO LTD-SPONS ADR (HMC) Stock Fundamental Analysis

NYSE:HMC - New York Stock Exchange, Inc. - US4381283088 - ADR

28.7  +0.46 (+1.63%)

After market: 28.76 +0.06 (+0.21%)

Fundamental Rating

5

Taking everything into account, HMC scores 5 out of 10 in our fundamental rating. HMC was compared to 42 industry peers in the Automobiles industry. HMC scores excellent on profitability, but there are concerns on its financial health. HMC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

HMC had positive earnings in the past year.
In the past year HMC had a positive cash flow from operations.
Each year in the past 5 years HMC has been profitable.
Each year in the past 5 years HMC had a positive operating cash flow.
HMC Yearly Net Income VS EBIT VS OCF VS FCFHMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T 2T

1.2 Ratios

With a decent Return On Assets value of 3.37%, HMC is doing good in the industry, outperforming 80.00% of the companies in the same industry.
HMC's Return On Equity of 7.95% is fine compared to the rest of the industry. HMC outperforms 75.00% of its industry peers.
With a decent Return On Invested Capital value of 5.17%, HMC is doing good in the industry, outperforming 80.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HMC is significantly below the industry average of 9.39%.
The 3 year average ROIC (3.75%) for HMC is below the current ROIC(5.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.37%
ROE 7.95%
ROIC 5.17%
ROA(3y)3.1%
ROA(5y)2.91%
ROE(3y)7.1%
ROE(5y)6.84%
ROIC(3y)3.75%
ROIC(5y)3.43%
HMC Yearly ROA, ROE, ROICHMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

HMC's Profit Margin of 4.56% is fine compared to the rest of the industry. HMC outperforms 80.00% of its industry peers.
HMC's Profit Margin has improved in the last couple of years.
HMC has a better Operating Margin (6.61%) than 82.50% of its industry peers.
HMC's Operating Margin has improved in the last couple of years.
HMC has a better Gross Margin (21.61%) than 85.00% of its industry peers.
HMC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.61%
PM (TTM) 4.56%
GM 21.61%
OM growth 3Y10.51%
OM growth 5Y8.15%
PM growth 3Y2.78%
PM growth 5Y7.13%
GM growth 3Y1.37%
GM growth 5Y0.74%
HMC Yearly Profit, Operating, Gross MarginsHMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HMC is destroying value.
Compared to 1 year ago, HMC has less shares outstanding
HMC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HMC has a worse debt to assets ratio.
HMC Yearly Shares OutstandingHMC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
HMC Yearly Total Debt VS Total AssetsHMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5T 10T 15T 20T 25T

2.2 Solvency

Based on the Altman-Z score of 1.81, we must say that HMC is in the distress zone and has some risk of bankruptcy.
HMC's Altman-Z score of 1.81 is fine compared to the rest of the industry. HMC outperforms 77.50% of its industry peers.
HMC has a Debt/Equity ratio of 0.50. This is a neutral value indicating HMC is somewhat dependend on debt financing.
HMC has a Debt to Equity ratio (0.50) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 1.81
ROIC/WACC0.75
WACC6.92%
HMC Yearly LT Debt VS Equity VS FCFHMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2T 4T 6T 8T 10T

2.3 Liquidity

HMC has a Current Ratio of 1.43. This is a normal value and indicates that HMC is financially healthy and should not expect problems in meeting its short term obligations.
HMC's Current ratio of 1.43 is in line compared to the rest of the industry. HMC outperforms 55.00% of its industry peers.
HMC has a Quick Ratio of 1.12. This is a normal value and indicates that HMC is financially healthy and should not expect problems in meeting its short term obligations.
HMC has a Quick ratio (1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.12
HMC Yearly Current Assets VS Current LiabilitesHMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2T 4T 6T 8T 10T

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.75% over the past year.
HMC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.17% yearly.
HMC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.28%.
The Revenue has been growing slightly by 5.16% on average over the past years.
EPS 1Y (TTM)4.75%
EPS 3Y-15.97%
EPS 5Y-8.17%
EPS Q2Q%-58.46%
Revenue 1Y (TTM)17.28%
Revenue growth 3Y15.76%
Revenue growth 5Y5.16%
Sales Q2Q%8.19%

3.2 Future

HMC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.21% yearly.
The Revenue is expected to grow by 2.95% on average over the next years.
EPS Next Y1.08%
EPS Next 2Y2.16%
EPS Next 3Y3.21%
EPS Next 5YN/A
Revenue Next Year5.53%
Revenue Next 2Y2.93%
Revenue Next 3Y2.95%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HMC Yearly Revenue VS EstimatesHMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5T 10T 15T 20T
HMC Yearly EPS VS EstimatesHMC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500 1K 1.5K

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.14 indicates a rather cheap valuation of HMC.
Based on the Price/Earnings ratio, HMC is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
HMC is valuated cheaply when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.19, the valuation of HMC can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HMC indicates a rather cheap valuation: HMC is cheaper than 92.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, HMC is valued rather cheaply.
Industry RankSector Rank
PE 7.14
Fwd PE 6.19
HMC Price Earnings VS Forward Price EarningsHMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

97.50% of the companies in the same industry are more expensive than HMC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.42
HMC Per share dataHMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HMC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)6.59
PEG (5Y)N/A
EPS Next 2Y2.16%
EPS Next 3Y3.21%

6

5. Dividend

5.1 Amount

HMC has a Yearly Dividend Yield of 4.67%, which is a nice return.
Compared to an average industry Dividend Yield of 3.90, HMC pays a better dividend. On top of this HMC pays more dividend than 95.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, HMC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.67%

5.2 History

The dividend of HMC decreases each year by -14.82%.
HMC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-14.82%
Div Incr Years0
Div Non Decr Years0
HMC Yearly Dividends per shareHMC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

HMC pays out 33.52% of its income as dividend. This is a sustainable payout ratio.
DP33.52%
EPS Next 2Y2.16%
EPS Next 3Y3.21%
HMC Yearly Income VS Free CF VS DividendHMC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T
HMC Dividend Payout.HMC Dividend Payout, showing the Payout Ratio.HMC Dividend Payout.PayoutRetained Earnings

HONDA MOTOR CO LTD-SPONS ADR

NYSE:HMC (1/21/2025, 8:04:00 PM)

After market: 28.76 +0.06 (+0.21%)

28.7

+0.46 (+1.63%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)02-07 2025-02-07/amc
Inst Owners44.48%
Inst Owner Change-0.21%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap44.38B
Analysts77.5
Price Target27.89 (-2.82%)
Short Float %0.24%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 4.67%
Yearly Dividend49.25
Dividend Growth(5Y)-14.82%
DP33.52%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-28 2025-03-28 (34)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-28.78%
Min EPS beat(2)-68.3%
Max EPS beat(2)10.74%
EPS beat(4)3
Avg EPS beat(4)10.05%
Min EPS beat(4)-68.3%
Max EPS beat(4)94.25%
EPS beat(8)5
Avg EPS beat(8)9.52%
EPS beat(12)7
Avg EPS beat(12)8.81%
EPS beat(16)11
Avg EPS beat(16)29.12%
Revenue beat(2)2
Avg Revenue beat(2)0.91%
Min Revenue beat(2)0.36%
Max Revenue beat(2)1.46%
Revenue beat(4)3
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.46%
Revenue beat(8)3
Avg Revenue beat(8)-0.64%
Revenue beat(12)6
Avg Revenue beat(12)0.07%
Revenue beat(16)9
Avg Revenue beat(16)0.53%
PT rev (1m)-22.93%
PT rev (3m)-23.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.5%
Revenue NY rev (1m)1.21%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 7.14
Fwd PE 6.19
P/S 0.32
P/FCF N/A
P/OCF 15.92
P/B 0.56
P/tB 0.61
EV/EBITDA 5.42
EPS(TTM)4.02
EY14.01%
EPS(NY)4.64
Fwd EY16.16%
FCF(TTM)-1.23
FCFYN/A
OCF(TTM)1.8
OCFY6.28%
SpS89.37
BVpS51.23
TBVpS47.06
PEG (NY)6.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.37%
ROE 7.95%
ROCE 6.73%
ROIC 5.17%
ROICexc 6.75%
ROICexgc 7.19%
OM 6.61%
PM (TTM) 4.56%
GM 21.61%
FCFM N/A
ROA(3y)3.1%
ROA(5y)2.91%
ROE(3y)7.1%
ROE(5y)6.84%
ROIC(3y)3.75%
ROIC(5y)3.43%
ROICexc(3y)4.78%
ROICexc(5y)4.31%
ROICexgc(3y)16.09%
ROICexgc(5y)16.15%
ROCE(3y)5.21%
ROCE(5y)4.8%
ROICexcg growth 3Y-39.49%
ROICexcg growth 5Y7.24%
ROICexc growth 3Y19.37%
ROICexc growth 5Y7.24%
OM growth 3Y10.51%
OM growth 5Y8.15%
PM growth 3Y2.78%
PM growth 5Y7.13%
GM growth 3Y1.37%
GM growth 5Y0.74%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 2.82
Cap/Depr 93.27%
Cap/Sales 3.4%
Interest Coverage 3.7
Cash Conversion 19.68%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 1.12
Altman-Z 1.81
F-Score6
WACC6.92%
ROIC/WACC0.75
Cap/Depr(3y)79.26%
Cap/Depr(5y)82.4%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.6%
Profit Quality(3y)138.76%
Profit Quality(5y)115.71%
High Growth Momentum
Growth
EPS 1Y (TTM)4.75%
EPS 3Y-15.97%
EPS 5Y-8.17%
EPS Q2Q%-58.46%
EPS Next Y1.08%
EPS Next 2Y2.16%
EPS Next 3Y3.21%
EPS Next 5YN/A
Revenue 1Y (TTM)17.28%
Revenue growth 3Y15.76%
Revenue growth 5Y5.16%
Sales Q2Q%8.19%
Revenue Next Year5.53%
Revenue Next 2Y2.93%
Revenue Next 3Y2.95%
Revenue Next 5YN/A
EBIT growth 1Y39.47%
EBIT growth 3Y27.92%
EBIT growth 5Y13.73%
EBIT Next Year23964.8%
EBIT Next 3Y533.37%
EBIT Next 5YN/A
FCF growth 1Y-113.75%
FCF growth 3Y-35.69%
FCF growth 5Y-3.79%
OCF growth 1Y-83.99%
OCF growth 3Y-11.34%
OCF growth 5Y-0.75%